Ginesnoside inhibited the proliferation, migration, and invasion of breast cancer, colorectal cancer, lung cancer, ovarian cancer, and glioblastoma cells by inhibiting VEGF, angiogenesis, and downregulating MMP-9 (81–83). The gene discussed is MMP9; the disease is lung carcinoma.